Comerica Securities’s Medpace MEDP Stock Holding History

Comerica Securities’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-73	Closed	-$15.5K	–	1023
2022 Q4	$15.5K	Buy	+73	New	+$14.6K	﹤0.01%	956

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Comerica Securities's MEDP Position: Q1 2023 in Review

Comerica Securities sold out of Medpace (MEDP) in Q1 2023, closing a stake of 73 shares — an estimated $15.5K sold.

Comerica Securities first reported a position in MEDP in Q4 2022 and held it in 1 quarter. The position peaked at $15.5K in Q4 2022. 416 funds tracked by Wall St. Rank hold MEDP as of Q1 2023.

Comerica Securities reported no remaining Medpace position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 73 Medpace shares in Q1 2023, an estimated $15.5K.
Comerica Securities first reported a position in Medpace in Q4 2022 and held it in 1 quarter.
Comerica Securities's Medpace position peaked at $15.5K in Q4 2022.
416 funds tracked by Wall St. Rank held Medpace as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.